EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
30 hedge funds and large institutions have $10.4M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
30
Holding in Top 10
2
Calls
$43K
Puts
–
Top Buyers
| 1 | +$24.4K | |
| 2 | +$14.4K | |
| 3 | +$10.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.18K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.78K |